CN106620914A - 体外循环人造肺 - Google Patents
体外循环人造肺 Download PDFInfo
- Publication number
- CN106620914A CN106620914A CN201610911062.7A CN201610911062A CN106620914A CN 106620914 A CN106620914 A CN 106620914A CN 201610911062 A CN201610911062 A CN 201610911062A CN 106620914 A CN106620914 A CN 106620914A
- Authority
- CN
- China
- Prior art keywords
- blister cavities
- blood
- lung
- oxygen
- aerofluxuss
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004072 lung Anatomy 0.000 title claims abstract description 63
- 230000002612 cardiopulmonary effect Effects 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 claims abstract description 69
- 239000008280 blood Substances 0.000 claims abstract description 65
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 59
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 59
- 239000001301 oxygen Substances 0.000 claims abstract description 59
- 239000007789 gas Substances 0.000 claims abstract description 32
- 230000004087 circulation Effects 0.000 claims description 16
- 238000001914 filtration Methods 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 11
- 230000004888 barrier function Effects 0.000 claims description 9
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004090 dissolution Methods 0.000 claims description 4
- 244000005700 microbiome Species 0.000 claims description 4
- 230000000977 initiatory effect Effects 0.000 claims description 3
- 238000004513 sizing Methods 0.000 claims description 3
- 210000000115 thoracic cavity Anatomy 0.000 claims description 3
- 239000002912 waste gas Substances 0.000 claims description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 102000001554 Hemoglobins Human genes 0.000 claims description 2
- 108010054147 Hemoglobins Proteins 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 210000003743 erythrocyte Anatomy 0.000 claims description 2
- 239000007943 implant Substances 0.000 claims description 2
- 230000003993 interaction Effects 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 210000001370 mediastinum Anatomy 0.000 claims description 2
- 239000013642 negative control Substances 0.000 claims description 2
- 210000001147 pulmonary artery Anatomy 0.000 claims description 2
- 238000002271 resection Methods 0.000 claims description 2
- 210000000779 thoracic wall Anatomy 0.000 claims description 2
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- 210000003437 trachea Anatomy 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims 1
- 230000003878 venous anastomosis Effects 0.000 claims 1
- 230000006870 function Effects 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 9
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract description 4
- 206010021143 Hypoxia Diseases 0.000 abstract description 3
- 210000003462 vein Anatomy 0.000 abstract description 3
- 230000002503 metabolic effect Effects 0.000 abstract description 2
- 230000007547 defect Effects 0.000 abstract 2
- 230000007954 hypoxia Effects 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 150000002926 oxygen Chemical class 0.000 abstract 1
- 230000009325 pulmonary function Effects 0.000 abstract 1
- 210000001736 capillary Anatomy 0.000 description 18
- 230000035479 physiological effects, processes and functions Effects 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 108010022579 ATP dependent 26S protease Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 210000003492 pulmonary vein Anatomy 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1621—Constructional aspects thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3666—Cardiac or cardiopulmonary bypass, e.g. heart-lung machines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Emergency Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
本发明涉及一种体外循环人造肺,其特征是引流人体表浅较大静脉血管内的静脉血,在体外由肺囊腔、吸氧囊腔、隔膜和毛细血管束组成的肺囊腔内进行气体交换,产生过饱和氧含量的动脉血,返输回静脉血管参与人体的代谢循环,本发明与人体生理肺气体交换过程相比,以单向、分段持续的方式,替代呼与吸在同一套通气管路和功能单位内双向往返,间断交替进行的气体交换模式,效率更高、交换更彻底,与现行医疗中通过改善供气质量,增加数量等对症疗法相比,从源头上改变机体缺氧状况的内在本质缺陷,具有独立、独特、不依赖生理肺完成气体交换特点,具有取代和补偿,肺功能缺损和不足的显著优点。
Description
一、技术领域:
本发明属于人体医学人造器官,具体的说是一种体外循环人造肺。
二、背景技术:
呼吸运动和功能是人体生命存在的最重要和首要的显性体征。呼吸系统的核心主体是肺,而肺是现代医学可移植和替代的脏器中实施操作中技术含量高、难度大,而效果尚不理想的治疗手段。因此,因肺的疾病和损伤威胁生命的患者,其生存希望更渺茫和淡泊。现有技术应对缺氧和呼吸困难的患者,主要是从呼吸的动力及气体供给的质和量等方面对症处置,但对因肺的结构和功能造成的气体交换障碍患者收效不大。
三、发明内容
本发明的目的是针对以上问题和现状,从生理学的角度提供一种改善血氧含量、满足机体代谢氧需求的体外循环人造肺。
本发明的目的是通过以下技术方案实现的:
一种体外循环人造肺,包括肺囊腔、排气囊腔、吸氧囊腔、隔膜、静脉血入口、动脉血出口、毛细血管、排气口、氧气输入口、负压控制滤过阀和正压控制滤过阀,其特征是肺囊腔为具有弹性定型支撑力的柔性囊腔,由隔膜横向分隔为排气囊腔和吸氧囊腔两部分;排气囊腔设置有负压控制滤过阀的排气口,吸氧囊腔设置有正压控制滤过阀的氧气输入口;排气囊腔的起始端设置静脉入口,进入排气囊腔后立即分流为毛细血管束;吸氧囊腔末端设置动脉血出口,动脉血出口汇集由排气囊腔系数穿过隔膜并贯穿吸氧囊腔全程的毛细血管;毛细血管为由透气不透水的半透膜制作的具有弹性支撑功能的毛细管;由静脉血入口输入的静脉血在毛细血管内流动,由于排气囊腔的负压环境影响,血液内溶解的,以二氧化碳为主的气体迅速弥散于囊腔并由排气口排出;低气体溶解浓度的血液经纵隔膜进入吸氧囊腔,由于吸氧囊腔内的正压纯氧环境影响,及红细胞及血红蛋白的主动亲和作用和血液的溶解作用,氧气迅速弥散进入毛细血管形成动脉血,众多毛细血管汇集后由动脉血出口排出;连接于排气口的负压控制滤过阀维持排气囊腔内持续稳定的负压环境并防止微生物及杂尘返流进入排气囊腔;连接于氧气输入口的正压控制滤过阀维持吸氧囊腔内持续稳定的正压环境并防止微生物及杂尘进入吸氧囊腔。
所述的体外循环人造肺,其特征是通过氧气输入口进入吸氧囊腔的氧气于输入前进行加湿处置。
所述的体外循环人造肺,其特征是肺囊腔内充盈等渗液体,排气囊腔内毛细血管血液所含二氧化碳为主的废气先行弥散溶解于等渗液体,再由等渗液体溢出游离间接排出,或以循环等渗液体方式直接排出,吸氧囊腔内低气体含量的血液在正压过饱和纯氧等渗液体中,通过毛细血管半透膜壁弥散,间接结合和溶解氧气经动脉血出口排出;所述充满等渗液体的排气囊腔和吸氧囊腔上部允许出现气体空泡。
所述的体外循环人造肺,其特征是对人造肺形态和弹性性能进行与人体胸腔的匹配适应性设置,将囊腔肺植入部分或全部切除肺叶的胸腔,氧气输入口及正负控制过滤阀由胸壁引出,排气口与气管吻合,肺脉血入口与肺动脉吻合,动脉血出口与肺静脉吻合,实现体内循环,体外控制的人造肺。
动物进化过程中肺的发生和发展完善,能够直接从气态环境中捕获氧气完成代谢过程,大大提高了有肺动物的活动范围和适应环境的能力,是动物从海洋走向陆地的关键。但是通过肺获取氧气的生理过程是通过复杂的固定通道、功能单位吸与呼的往返过程实现的,极大的局限了气体代谢的功能和效率。不能不说是动物进化过程中发生的方向性缺陷,为其后进化出的多样性高级动物,特别是顶端的人类遗留的重大遗憾。
本发明的体外循环人造肺仿照现存高级水生有腮动物和高级陆生动物离水前获取氧气的代谢方式:通过单向的、分段连续的、具有负正压动力的技术方案,完成呼吸的代谢过程,具有突出的实质性特点和显著的进步:
1、与人体呼吸的正常生理过程和机能相比,本发明的囊腔肺消除了人体生理肺存在的:(1)吸气与呼气过程是不间断交替进行的,多数时间都损耗在气体的流动过程之中,给气体交替提供的时间极其短暂。(2)吸入的新鲜空气向血液内的弥散,血液内以二氧化碳为主的废气向肺泡内的溢散,是在肺泡内的混合过程中同时实现的,其混合过程首先是降低了所有气体的分压差,而气体分压差是弥散和溢散速率的最主要动力来源。(3)由于吸气与呼气过程在同一套通道和功能单位中交替进行,基本固定的气管通道容积和依赖弹性张缩的肺泡积存着大量无功能死腔气,或称残气,使进入肺泡进行交换的新鲜气体量占比明显减少。(4)人体完成吸气与呼气的动力是胸腔变形造成的腔负正压实现的,但这种负正压仅局限于气体的流动,较少存在与气体的内在交换存在匹配性。本发明的囊腔肺在所有时间和空间范围内,以最大气体分压差保证气体的溢散和弥散过程,外加负、正压的辅助动力,能够以高速度、高质量、大数量完成气体交换,能以较少量体表静脉血部分血流通过囊腔肺内的气体交换,获得和携带大量氧气,取代或补偿人体生理肺的气体交换功能。
2、与现行医疗体系中应对呼吸困难、缺氧患者所采用的提高供气氧含量或机械性增加潮气量等措施相比:本发明完全或部分撇开机能或功能不全的生理肺,直接对运输氧气至组织的载体血液供氧,不受或少受生理肺功能状态的限制,更积极主动、有效和可靠。
3、本发明的体外循环人造肺在与生理肺不发生联系的状态下独立完成机体与环境的气体交换,对生理肺机械动作不产生关联,生理肺尚还具备的残余功能仍可照常进行,其附带的发声交流功能不受影响。
四、附图说明:
图1为体外循环人造肺的肺囊腔侧剖面示意图。
图2为体外循环人造肺的肺囊腔横断面示意图。
图中:1肺囊腔、2排气囊腔、3吸氧囊腔、4隔膜、5静脉血入口、6动脉血出口、7毛细血管、8排气口、9氧气输入口、10负压控制滤过阀、11正压控制滤过阀。
五、具体实施方式:
下面结合说明书附图对本发明作进一步详细说明:
如力1、图2所示,肺囊腔1为用具有弹性定型支持力材料制作的长筒状柔性囊腔,囊腔中部设置一隔膜4分隔为排气囊腔2和吸氧囊腔3。肺囊腔1的起始端设置静脉血入口5和排气口8,静脉血进入肺囊腔1后即分流为众多毛细血管7组成的毛细血管束,毛细血管7为用透气不透水的半透膜制作为具有弹性支撑功能的并列毛细管。毛细血管7由排气囊腔2系数穿过隔膜4进入吸氧囊腔3。毛细血管7于肺囊腔1末端汇集经由动脉血出口6排出返回。肺囊腔1的末端上设置氧气输入口9。排气口8排出气体的管线上设置负压控制滤过阀10,氧气输入口9输入氧气的管线上设置正压控制滤过阀11。
使用时,整套体外循环人造肺进行杀菌消毒处理,血液流经部位进行致热源消除处理并充注等渗盐水至无气泡残存,通过管线将表浅大静脉血液经静脉血入口5导入肺囊腔1内的毛细血管束,完成气体交换后汇集经动脉血出口6输出返回表浅大静脉。排气囊腔2通过负压控制滤过阀10保持稳定负压状态并防止异物逆向进入排气囊腔2,氧气经正压控制滤过阀11通过氧气输入口5进入吸氧囊腔3并保持稳定正压供给和防止异物随同进入。
除说明书所述的技术特征外,均为本专业技术人员的已知技术。
Claims (4)
1.一种体外循环人造肺,包括肺囊腔、排气囊腔、吸氧囊腔、隔膜、静脉血入口、动脉血出口、毛细血管、排气口、氧气输入口、负压控制滤过阀和正压控制滤过阀,其特征是肺囊腔为具有弹性定型支撑力的柔性囊腔,由隔膜横向分隔为排气囊腔和吸氧囊腔两部分;排气囊腔设置有负压控制滤过阀的排气口,吸氧囊腔设置有正压控制滤过阀的氧气输入口;排气囊腔的起始端设置静脉入口,进入排气囊腔后立即分流为毛细血管束;吸氧囊腔末端设置动脉血出口,动脉血出口汇集由排气囊腔系数穿过隔膜并贯穿吸氧囊腔全程的毛细血管;毛细血管为由透气不透水的半透膜制作的具有弹性支撑功能的毛细管;由静脉血入口输入的静脉血在毛细血管内流动,由于排气囊腔的负压环境影响,血液内溶解的,以二氧化碳为主的气体迅速弥散于囊腔并由排气口排出;低气体溶解浓度的血液经纵隔膜进入吸氧囊腔,由于吸氧囊腔内的正压纯氧环境影响,及红细胞及血红蛋白的主动亲和作用和血液的溶解作用,氧气迅速弥散进入毛细血管形成动脉血,众多毛细血管汇集后由动脉血出口排出;连接于排气口的负压控制滤过阀维持排气囊腔内持续稳定的负压环境并防止微生物及杂尘返流进入排气囊腔;连接于氧气输入口的正压控制滤过阀维持吸氧囊腔内持续稳定的正压环境并防止微生物及杂尘进入吸氧囊腔。
2.根据权利要求1所述的体外循环人造肺,其特征是通过氧气输入口进入吸氧囊腔的氧气于输入前进行加湿处置。
3.根据权利要求1所述的体外循环人造肺,其特征是肺囊腔内充盈等渗液体,排气囊腔内毛细血管血液所含二氧化碳为主的废气先行弥散溶解于等渗液体,再由等渗液体溢出游离间接排出,或以循环等渗液体方式直接排出,吸氧囊腔内低气体含量的血液在正压过饱和纯氧等渗液体中,通过毛细血管半透膜壁弥散,间接结合和溶解氧气经动脉血出口排出;所述充满等渗液体的排气囊腔和吸氧囊腔上部允许出现气体空泡。
4.根据权利要求1所述的体外循环人造肺,其特征是对人造肺形态和弹性性能进行与人体胸腔的匹配适应性设置,将囊腔肺植入部分或全部切除肺叶的胸腔,氧气输入口及正负控制过滤阀由胸壁引出,排气口与气管吻合,肺脉血入口与肺动脉吻合,动脉血出口与肺静脉吻合,实现体内循环,体外控制的人造肺。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610911062.7A CN106620914B (zh) | 2016-10-20 | 2016-10-20 | 体外循环人造肺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610911062.7A CN106620914B (zh) | 2016-10-20 | 2016-10-20 | 体外循环人造肺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106620914A true CN106620914A (zh) | 2017-05-10 |
CN106620914B CN106620914B (zh) | 2018-12-28 |
Family
ID=58856236
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610911062.7A Active CN106620914B (zh) | 2016-10-20 | 2016-10-20 | 体外循环人造肺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106620914B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109003522A (zh) * | 2018-10-12 | 2018-12-14 | 中国人民解放军海军军医大学海军医学研究所 | 减压病模拟人 |
CN109192033A (zh) * | 2018-10-12 | 2019-01-11 | 中国人民解放军海军军医大学海军医学研究所 | 一种人体减压病模拟模型及其构建方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076867A (zh) * | 1992-04-04 | 1993-10-06 | 赵伟 | 植入式人工肺 |
CN1160529A (zh) * | 1997-01-30 | 1997-10-01 | 乔建民 | 体内膜肺 |
US6267926B1 (en) * | 1998-10-08 | 2001-07-31 | Celgard Inc. | Device for removing entrained gases from liquids |
JP2005192780A (ja) * | 2004-01-07 | 2005-07-21 | Dainippon Ink & Chem Inc | 人工肺 |
-
2016
- 2016-10-20 CN CN201610911062.7A patent/CN106620914B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1076867A (zh) * | 1992-04-04 | 1993-10-06 | 赵伟 | 植入式人工肺 |
CN1160529A (zh) * | 1997-01-30 | 1997-10-01 | 乔建民 | 体内膜肺 |
US6267926B1 (en) * | 1998-10-08 | 2001-07-31 | Celgard Inc. | Device for removing entrained gases from liquids |
JP2005192780A (ja) * | 2004-01-07 | 2005-07-21 | Dainippon Ink & Chem Inc | 人工肺 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109003522A (zh) * | 2018-10-12 | 2018-12-14 | 中国人民解放军海军军医大学海军医学研究所 | 减压病模拟人 |
CN109192033A (zh) * | 2018-10-12 | 2019-01-11 | 中国人民解放军海军军医大学海军医学研究所 | 一种人体减压病模拟模型及其构建方法 |
CN109003522B (zh) * | 2018-10-12 | 2021-10-22 | 中国人民解放军海军军医大学海军医学研究所 | 减压病模拟人 |
Also Published As
Publication number | Publication date |
---|---|
CN106620914B (zh) | 2018-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6983793B2 (ja) | 体外での肺補助のための方法 | |
CN104800902B (zh) | 用于救治多器官功能衰竭的体外循环生命支持设备 | |
JP7013380B2 (ja) | 体外での二酸化炭素除去のための方法 | |
ITMI20070913A1 (it) | Metodo di trattamento del sangue atto ad eliminare almeno parzialmente il contenuto di anidride carbonica e relativo dispositivo. | |
WO2023284150A1 (zh) | 膜式氧合器 | |
US20200188568A1 (en) | System and method for hypobaric oxygenation with membrane oxygenator | |
US11654225B2 (en) | Wearable modular extracorporeal life support device for mobile treatment of single and multiorgan failure | |
JP7213556B2 (ja) | 二酸化炭素を除去するための方法およびシステム | |
TWI815547B (zh) | 集成式膜式氧合器 | |
CN106620914A (zh) | 体外循环人造肺 | |
US9511053B2 (en) | Nitric oxide scavengers | |
CN112043896A (zh) | 一种体外循环系统 | |
CN100484512C (zh) | 一种高氧大输液体的制备方法 | |
Boron | Organization of the respiratory system | |
CN1093005A (zh) | 一体化囊状人工心肺泵 | |
Khambatta et al. | Effect of sodium nitroprusside-induced hypotension on pulmonary deadspace | |
CN105983147A (zh) | 一种肾内科血液透析过滤器 | |
CN219049761U (zh) | 一种可远程监控的平战兼用血液净化超滤系统 | |
CN102500004B (zh) | 血液净化治疗给氧仪 | |
Awad et al. | Extracorporeal oxygenation with hydrogen peroxide: a preliminary report | |
CN113578055A (zh) | 婴幼儿体外循环预充液超滤装置及方法 | |
CN2640478Y (zh) | 便携式体外转流膜肺机 | |
Kawahito et al. | Preclinical evaluation of a new hollow fiber silicone membrane oxygenator for pediatric cardiopulmonary bypass: ex-vivo study | |
CN112354034A (zh) | 一种鱼腮式体外循环氧合器系统 | |
Черній et al. | THE INFLUENCE OF BIOCOMPATIBILITY OF THE EXTRACORPOREAL OXYGENATOR CIRCUIT ON THE DEGREE OF HEMOLYSIS AND OPTIMIZATION OF OXYGEN STATUS IN MINIMALLY INVASIVE CORONARY ARTERY BYPASS GRAFTING |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200630 Address after: No. 409 Yanqi Industrial Development Zone, Huairou, Beijing Patentee after: Beijing meadows Medical Equipment Co., Ltd Address before: 250013 Shandong Province, Lixia District of Ji'nan City Luo River District No. 8 unit 4, Room 301 Patentee before: Dong Lantian |
|
TR01 | Transfer of patent right |